Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 8 studies | 18% ± 2% | |
CD8-positive, alpha-beta T cell | 7 studies | 20% ± 4% | |
B cell | 4 studies | 22% ± 5% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 2% | |
epithelial cell | 4 studies | 28% ± 8% | |
abnormal cell | 4 studies | 21% ± 3% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 20% ± 5% | |
naive B cell | 4 studies | 21% ± 3% | |
mature NK T cell | 3 studies | 17% ± 1% | |
retinal rod cell | 3 studies | 45% ± 21% | |
exhausted T cell | 3 studies | 18% ± 2% | |
dendritic cell | 3 studies | 24% ± 5% | |
goblet cell | 3 studies | 17% ± 1% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
CD4-positive, alpha-beta memory T cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 4 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3384.85 | 1445 / 1445 | 100% | 55.60 | 183 / 183 |
liver | 100% | 1661.88 | 226 / 226 | 100% | 48.74 | 406 / 406 |
ovary | 100% | 2959.21 | 180 / 180 | 100% | 53.58 | 430 / 430 |
skin | 100% | 3772.47 | 1809 / 1809 | 100% | 91.92 | 472 / 472 |
thymus | 100% | 3410.84 | 653 / 653 | 100% | 65.45 | 604 / 605 |
brain | 100% | 2071.03 | 2637 / 2642 | 100% | 66.48 | 705 / 705 |
prostate | 100% | 3375.99 | 245 / 245 | 100% | 55.02 | 501 / 502 |
uterus | 100% | 3870.52 | 170 / 170 | 100% | 90.95 | 458 / 459 |
breast | 100% | 3449.46 | 459 / 459 | 100% | 98.61 | 1115 / 1118 |
pancreas | 100% | 1647.71 | 327 / 328 | 100% | 60.75 | 178 / 178 |
lung | 100% | 3244.72 | 577 / 578 | 100% | 64.16 | 1153 / 1155 |
stomach | 100% | 2566.32 | 359 / 359 | 100% | 56.33 | 285 / 286 |
intestine | 100% | 3634.64 | 966 / 966 | 100% | 66.20 | 525 / 527 |
kidney | 100% | 2462.44 | 89 / 89 | 99% | 45.31 | 894 / 901 |
adrenal gland | 100% | 4086.54 | 258 / 258 | 99% | 49.68 | 228 / 230 |
bladder | 100% | 3493.38 | 21 / 21 | 99% | 72.02 | 499 / 504 |
adipose | 100% | 3337.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3350.80 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 53.97 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 147.17 | 29 / 29 |
spleen | 100% | 5716.82 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 83.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 78.83 | 1 / 1 |
muscle | 100% | 2679.59 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1743.19 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3696.51 | 919 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903936 | Biological process | cellular response to sodium arsenite |
GO_0007254 | Biological process | JNK cascade |
GO_0010468 | Biological process | regulation of gene expression |
GO_0034620 | Biological process | cellular response to unfolded protein |
GO_0034605 | Biological process | cellular response to heat |
GO_0036480 | Biological process | neuron intrinsic apoptotic signaling pathway in response to oxidative stress |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0006338 | Biological process | chromatin remodeling |
GO_0031396 | Biological process | regulation of protein ubiquitination |
GO_0006334 | Biological process | nucleosome assembly |
GO_0045860 | Biological process | positive regulation of protein kinase activity |
GO_0071280 | Biological process | cellular response to copper ion |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0072738 | Biological process | cellular response to diamide |
GO_0030521 | Biological process | androgen receptor signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0000775 | Cellular component | chromosome, centromeric region |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0016605 | Cellular component | PML body |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0042393 | Molecular function | histone binding |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0030295 | Molecular function | protein kinase activator activity |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0002039 | Molecular function | p53 binding |
GO_0050681 | Molecular function | nuclear androgen receptor binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DAXX |
Protein name | Death domain-associated protein 6 (Daxx) Death domain-associated protein 6 (Daxx) (hDaxx) (ETS1-associated protein 1) (EAP1) (Fas death domain-associated protein) Death domain associated protein Death domain-associated protein 6 Death domain associated protein (Death domain-associated protein 6) |
Synonyms | BING2 DAP6 |
Description | FUNCTION: Transcription corepressor known to repress transcriptional potential of several sumoylated transcription factors. Down-regulates basal and activated transcription. Its transcription repressor activity is modulated by recruiting it to subnuclear compartments like the nucleolus or PML/POD/ND10 nuclear bodies through interactions with MCSR1 and PML, respectively. Seems to regulate transcription in PML/POD/ND10 nuclear bodies together with PML and may influence TNFRSF6-dependent apoptosis thereby. Inhibits transcriptional activation of PAX3 and ETS1 through direct protein-protein interactions. Modulates PAX5 activity; the function seems to involve CREBBP. Acts as an adapter protein in a MDM2-DAXX-USP7 complex by regulating the RING-finger E3 ligase MDM2 ubiquitination activity. Under non-stress condition, in association with the deubiquitinating USP7, prevents MDM2 self-ubiquitination and enhances the intrinsic E3 ligase activity of MDM2 towards TP53, thereby promoting TP53 ubiquitination and subsequent proteasomal degradation. Upon DNA damage, its association with MDM2 and USP7 is disrupted, resulting in increased MDM2 autoubiquitination and consequently, MDM2 degradation, which leads to TP53 stabilization. Acts as a histone chaperone that facilitates deposition of histone H3.3. Acts as a targeting component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Does not affect the ATPase activity of ATRX but alleviates its transcription repression activity. Upon neuronal activation associates with regulatory elements of selected immediate early genes where it promotes deposition of histone H3.3 which may be linked to transcriptional induction of these genes. Required for the recruitment of histone H3.3:H4 dimers to PML-nuclear bodies (PML-NBs); the process is independent of ATRX and facilitated by ASF1A; PML-NBs are suggested to function as regulatory sites for the incorporation of newly synthesized histone H3.3 into chromatin. In case of overexpression of centromeric histone variant CENPA (as found in various tumors) is involved in its mislocalization to chromosomes; the ectopic localization involves a heterotypic tetramer containing CENPA, and histones H3.3 and H4 and decreases binding of CTCF to chromatin. Proposed to mediate activation of the JNK pathway and apoptosis via MAP3K5 in response to signaling from TNFRSF6 and TGFBR2. Interaction with HSPB1/HSP27 may prevent interaction with TNFRSF6 and MAP3K5 and block DAXX-mediated apoptosis. In contrast, in lymphoid cells JNC activation and TNFRSF6-mediated apoptosis may not involve DAXX. Shows restriction activity towards human cytomegalovirus (HCMV). Plays a role as a positive regulator of the heat shock transcription factor HSF1 activity during the stress protein response . . |
Accessions | ENST00000419051.1 ENST00000454197.1 ENST00000428268.1 ENST00000446403.1 ENST00000414272.5 B4E1C1 ENST00000374542.10 [Q9UER7-1] ENST00000445009.6 [Q9UER7-1] ENST00000616312.1 [Q9UER7-4] ENST00000399060.7 [Q9UER7-1] ENST00000453931.5 ENST00000421874.1 ENST00000419855.5 ENST00000451280.1 ENST00000612868.4 [Q9UER7-3] ENST00000446511.1 A0A994J7Y1 ENST00000266000.10 [Q9UER7-1] ENST00000399344.7 [Q9UER7-1] ENST00000440500.1 ENST00000706094.1 ENST00000477162.1 A0A0G2JJZ4 ENST00000612888.2 [Q9UER7-3] Q4VX54 ENST00000457553.1 ENST00000429531.1 ENST00000613912.3 [Q9UER7-4] ENST00000617660.4 [Q9UER7-3] Q9UER7 A2AB94 ENST00000619421.1 [Q9UER7-4] ENST00000383062.8 [Q9UER7-1] ENST00000622655.1 [Q9UER7-4] ENST00000438332.5 ENST00000383194.8 [Q9UER7-1] ENST00000414083.6 [Q9UER7-3] ENST00000455860.6 [Q9UER7-1] ENST00000620164.4 [Q9UER7-4] ENST00000433482.5 [Q9UER7-1] ENST00000436311.6 [Q9UER7-1] |